Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles

References

• Shin T-H, Choi Y, Kim S, Cheon J. Recent advances in magnetic nanoparticle-based multi-modal imaging. Chem Soc Rev. 2015;44(14):4501–4516. doi:10.1039/c4cs00345d25652670
   PubMed Web of Science ®Google Scholar
• Fan W, Yung B, Huang P, Chen X. Nanotechnology for multimodal synergistic cancer therapy. Chem Rev. 2017;117(22):13566–13638. doi:10.1021/acs.chemrev.7b0025829048884
   PubMed Web of Science ®Google Scholar
• Johnson NJJ, He S, Nguyen Huu VA, Almutairi A. Compact micellization: a strategy for Ultrahigh T1 magnetic resonance contrast with gadolinium-based nanocrystals. ACS Nano. 2016;10(9):8299–8307. doi:10.1021/acsnano.6b0255927588579
   PubMedGoogle Scholar
• Qin L, Sun Z-Y, Cheng K, et al. Zwitterionic manganese and gadolinium metal–organic frameworks as efficient contrast agents for in vivo magnetic resonance imaging. ACS Appl Mater Interfaces. 2017;9(47):41378–41386. doi:10.1021/acsami.7b0960829144731
   PubMedGoogle Scholar
• Peng Y-K, Lui CNP, Chen Y-W, et al. Engineering of single magnetic particle carrier for living brain cell imaging: a tunable T1-/T2-/dual-modal contrast agent for magnetic resonance imaging application. Chem Mater. 2017;29(10):4411–4417. doi:10.1021/acs.chemmater.7b00884
   Web of Science ®Google Scholar
• Zhao Z, Chi X, Yang L, et al. Cation exchange of anisotropic-shaped magnetite nanoparticles generates high-relaxivity contrast agents for liver tumor imaging. Chem Mater. 2016;28(10):3497–3506. doi:10.1021/acs.chemmater.6b01256
   Web of Science ®Google Scholar
• Zhao Z, Zhou Z, Bao J, et al. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging. Nat Commun. 2013;4:2266. doi:10.1038/ncomms326623903002
   PubMedGoogle Scholar
• Na HB, Lee JH, An K, et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem-Int Ed. 2007;119(28):5493–5497. doi:10.1002/ange.200604775
   Google Scholar
• Zhao Z, Wang X, Zhang Z, et al. Real-time monitoring of arsenic trioxide release and delivery by activatable T1 imaging. ACS Nano. 2015;9(3):2749–2759. doi:10.1021/nn506640h25688714
   PubMedGoogle Scholar
• Zhao Z, Bao J, Fu C, Lei M, Cheng J. Controllable synthesis of manganese oxide nanostructures from 0-D to 3-D and mechanistic investigation of internal relation between structure and T1 relaxivity. Chem Mater. 2017;29(24):10455–10468. doi:10.1021/acs.chemmater.7b04100
   Web of Science ®Google Scholar
• Lei M, Fu C, Cheng X, et al. Activated surface charge-reversal manganese oxide nanocubes with high surface-to-volume ratio for accurate magnetic resonance tumor imaging. Adv Funct Mater. 2017;27(30):1700978. doi:10.1002/adfm.201700978
   Web of Science ®Google Scholar
• Werner EJ, Datta A, Jocher CJ, Raymond KN. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew Chem-Int Ed. 2008;47(45):8568–8580. doi:10.1002/anie.200800212
   PubMed Web of Science ®Google Scholar
• Ni K, Zhao Z, Zhang Z, et al. Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T1 contrast ability. Nanoscale. 2016;8(6):3768–3774. doi:10.1039/c5nr08402d26814592
   PubMedGoogle Scholar
• Ananta JS, Godin B, Sethi R, et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol. 2010;5:815. doi:10.1038/nnano.2010.20320972435
   PubMed Web of Science ®Google Scholar
• Paik T, Tr G, Am P, Yun H, Cb M. Designing tripodal and triangular gadolinium oxide nanoplates and self-assembled nanofibrils as potential multimodal bioimaging probes. ACS Nano. 2013;7(3):2850–2859. doi:10.1021/nn400458323432186
   PubMedGoogle Scholar
• Li F, Li Z, Jin X, et al. Ultra-small gadolinium oxide nanocrystal sensitization of non-small-cell lung cancer cells toward X-ray irradiation by promoting cytostatic autophagy. Int J Nanomedicine. 2019;14:2415–2431. doi:10.2147/IJN.S19367631040665
   PubMedGoogle Scholar
• Bae KH, Kim YB, Lee Y, Hwang J, Park H, Park TG. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast T1- and T2-weighted magnetic resonance imaging. Bioconjugate Chem. 2010;21(3):505–512. doi:10.1021/bc900424u
   PubMed Web of Science ®Google Scholar
• Yang H, Zhuang Y, Sun Y, et al. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials. 2011;32(20):4584–4593. doi:10.1016/j.biomaterials.2011.03.01821458063
   PubMed Web of Science ®Google Scholar
• Li F, Zhi D, Luo Y, et al. Core/shell Fe3O4/Gd2O3 nanocubes as T1–T2 dual modal MRI contrast agents. Nanoscale. 2016;8(25):12826–12833. doi:10.1039/c6nr02620f27297334
   PubMedGoogle Scholar
• J-s C, Lee J-H, Shin T-H, Song H-T, Kim EY, Cheon J. Self-confirming “AND” logic nanoparticles for fault-free MRI. J Am Chem Soc. 2010;132(32):11015–11017. doi:10.1021/ja104503g20698661
   PubMedGoogle Scholar
• Zhu X, Lin H, Wang L, et al. Activatable T1 relaxivity recovery nanoconjugates for kinetic and sensitive analysis of matrix metalloprotease 2. ACS Appl Mater Interfaces. 2017;9(26):21688–21696. doi:10.1021/acsami.7b0538928603956
   PubMedGoogle Scholar
• J-s C, Kim S, Yoo D, et al. Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets. Nat Mater. 2017;16:537. doi:10.1038/nmat484628166216
   PubMedGoogle Scholar
• Gallo J, Harriss BI, Hernández-Gil J, Bañobre-López M, Long NJ. Probing T1–T2 interactions and their imaging implications through a thermally responsive nanoprobe. Nanoscale. 2017;9(31):11318–11326. doi:10.1039/c7nr01733b28762407
   PubMedGoogle Scholar
• Keasberry NA, Bañobre-López M, Wood C, Stasiuk GJ, Gallo J, Long NJ. Tuning the relaxation rates of dual-mode T1/T2 nanoparticle contrast agents: a study into the ideal system. Nanoscale. 2015;7(38):16119–16128. doi:10.1039/c5nr04400f26371437
   PubMedGoogle Scholar
• Zhou Z, Huang D, Bao J, et al. A synergistically enhanced T1–T2 dual-modal contrast agent. Adv Mater. 2012;24(46):6223–6228. doi:10.1002/adma.20120316922972529
   PubMed Web of Science ®Google Scholar
• Santra S, Jativa SD, Kaittanis C, Normand G, Grimm J, Perez JM. Gadolinium-encapsulating iron oxide nanoprobe as activatable NMR/MRI contrast agent. ACS Nano. 2012;6(8):7281–7294. doi:10.1021/nn302393e22809405
   PubMedGoogle Scholar
• He Q, Shi J. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv Mater. 2014;26(3):391–411. doi:10.1002/adma.20130312324142549
   PubMedGoogle Scholar
• Chen Y, Chen H, Zeng D, et al. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano. 2010;4(10):6001–6013. doi:10.1021/nn101511720815402
   PubMed Web of Science ®Google Scholar
• Cao YC. Synthesis of square gadolinium-oxide nanoplates. J Am Chem Soc. 2004;126(24):7456–7457. doi:10.1021/ja048167615198589
   PubMedGoogle Scholar
• Hl D, Yx Z, Wang S, Jm X, Sc X, Gh L. Fe3O4@SiO2 Core/shell nanoparticles: the silica coating regulations with a single core for different core sizes and shell thicknesses. Chem Mater. 2012;24(23):4572–4580. doi:10.1021/cm302828d
   Web of Science ®Google Scholar
• Yi DK, Lee SS, Papaefthymiou GC, Ying JY. Nanoparticle architectures templated by SiO2/Fe2O3 nanocomposites. Chem Mater. 2006;18(3):614–619. doi:10.1021/cm0512979
   Web of Science ®Google Scholar
• Sato T, Shimosato T, Klinman DM. Silicosis and lung cancer: current perspectives. Lung Cancer. 2018;9:91–101. doi:10.2147/LCTT.S15637630498384
   PubMedGoogle Scholar
• Das M, Yi DK, An SS. Analyses of protein corona on bare and silica-coated gold nanorods against four mammalian cells. Int J Nanomedicine. 2015;10:1521–1545. doi:10.2147/IJN.S7618725759578
   PubMed Web of Science ®Google Scholar
• Wang L, Lin H, Ma L, et al. Albumin-based nanoparticles loaded with hydrophobic gadolinium chelates as T1–T2 dual-mode contrast agents for accurate liver tumor imaging. Nanoscale. 2017;9(13):4516–4523. doi:10.1039/c7nr01134b28317976
   PubMed Web of Science ®Google Scholar
• Wang L, Zhu X, Tang X, et al. A multiple gadolinium complex decorated fullerene as A highly sensitive T1 contrast agent. Chem Commun. 2015;51(21):4390–4393. doi:10.1039/C5CC00285K
   PubMed Web of Science ®Google Scholar
• Shin T-H, J-s C, Yun S, et al. T1 and T2 dual-mode MRI contrast agent for enhancing accuracy by engineered nanomaterials. ACS Nano. 2014;8(4):3393–3401. doi:10.1021/nn405977t24673493
   PubMedGoogle Scholar